Skip to main content

Table 2 Changes in respiratory variables during HFNC

From: Application of high-flow nasal cannula in hypoxemic patients with COVID-19: a retrospective cohort study

Variables

Time (h)

HFNC success

HFNC failure

P

RR

2

24 (22–26)

25 (23–27)

0.138

6

22 (21–24)

24 (23–26)

0.001

12

22 (20–25)

25 (24–25)

0.002

24

21 (20–23)

25 (25–28)

<0.001

SpO2/FiO2

2

153.2 (135.6–194.9)

158.3 (139.8–170.0)

0.157

6

158.6 (135.3–215.3)

123.8 (116.7–157.9)

<0.001

12

179.6 (136.1–206.5)

127.0 (115.3–161.7)

<0.001

24

182.7 (142.8–202.1)

126.4 (116.0–153.8)

<0.001

PaO2/FiO2

2

116.7 (93.8–143.8)

111.1 (100.0–125.0)

0.141

6

115.4 (100.8–164.3)

95.3 (83.5–120.3)

<0.001

12

130.0 (104.6–168.8)

90.7 (76.9–106.3)

<0.001

24

145.0 (107.2–167.3)

85.2 (72.9–110.9)

<0.001

ROX index

2

6.8 (5.6–7.8)

6.4 (4.9–7.6)

0.074

6

6.7 (5.9–9.5)

5.0 (4.6–6.5)

<0.001

12

7.9 (6.1–9.1)

5.0 (4.4–7.3)

<0.001

24

7.8 (6.6–10.0)

4.8 (4.4–6.0)

<0.001

  1. Each parameter is expressed as median (interquartile range). Parameters in each group were compared using the Mann-Whitney U test. RR respiratory rate, SpO2 pulse oxygen saturation, FiO2 fraction of inspired oxygen, PaO2 arterial partial pressure of oxygen, ROX index Respiratory rate-oxygenation index